Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
IVL2001 (ivermectin)
- Development stage
- Unknown
- Lead developer
- Inventage Lab
- Modality
- Small Molecules
- Administration
- Subcutaneous
01
Overview
IVL2001 is a long-acting, microsphere-based injectable formulation of **ivermectin** developed by **Inventage Lab** for the prevention of heartworm (*Dirofilaria immitis*) in dogs. Utilizing the proprietary **IVL-DrugFlow** platform, IVL2001 provides a sustained release of the active ingredient, enabling a three-month duration of protection from a single injection, which improves compliance compared to traditional monthly oral or topical treatments. The product was developed in collaboration with **Onheal** and is marketed under the brand name **Iverlong**. Ivermectin, the active component, is a macrocyclic lactone that induces paralysis and death in parasites by activating glutamate-gated chloride channels.
- Brand names
- Iverlong
- Other names
- ivermectin microsphere injection
02
Targets
GluCl (Glutamate-gated chloride channel)Glycine receptorCHRNA7 (α7 nicotinic receptor)P2RX4 (P2X Purinoceptor 4)
Beyond the preview
Go deeper on IVL2001 (ivermectin).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on IVL2001 (ivermectin).